Skip to Main Content

Paper Details

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.
J Urol
4
2021
Androgen, BCR, Men, Prostate Cancer, androgen, men, nonmetastatic castration resistant prostate cancer, patient, patients, prostate cancer, prostate specific antigen
Author NameAffiliation
Yongmei ChenCenter for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of Health Sciences
Mark C MarkowskiSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
David G McLeodCenter for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of Health Sciences
Bruce J TrockJohns Hopkins School of Medicine
Mario A EisenbergerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
  • 1 - 5

Datasets

Release 1.2